Trial Profile
A Randomized, Open Label, Single Dose, Two-way Crossover Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil Administered in Healthy Male Volunteer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Nov 2017
Price :
$35
*
At a glance
- Drugs YY 201 (Primary) ; Dutasteride; Tadalafil
- Indications Benign prostatic hyperplasia
- Focus Pharmacokinetics
- Sponsors Yuyu
- 21 Nov 2017 Status changed from active, no longer recruiting to completed.
- 14 Aug 2017 New trial record